Robert Montgomery

Sirolimus

2 trials

Cisplatin

Pharmacological Study

phase_2

Cystectomy

Docetaxel

Paclitaxel

phase_1

Prednisone

phase_2

Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer

+8 more interventions

16 unique interventions3 categories

Analytics

Trial Phases

Phase 13

Phase 24

Trial Status

Completed4

Terminated2

Role Distribution

Principal Investigator6

PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT03570476Phase 2Terminated

Prostate Adenocarcinoma Without Neuroendocrine DifferentiationStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+3 more

PrincipalinvestigatorStart date: 2018-09-11

NCT02881125Phase 1Completed

Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma

Small Cell Carcinoma

PrincipalinvestigatorStart date: 2016-11-03

NCT02565901Phase 1/2Terminated

Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma+1 more

PrincipalinvestigatorStart date: 2016-02-29

NCT01503229Phase 2Completed

Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Hormone-Resistant Prostate CancerMetastatic Prostate CarcinomaRecurrent Prostate Carcinoma+1 more

PrincipalinvestigatorStart date: 2012-12-01

NCT01731912Not ApplicableCompleted

Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer

Prostate AdenocarcinomaStage IIA Prostate CancerStage IIB Prostate Cancer+2 more

Principalinvestigator

NCT01938573Phase 1/2Completed

Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer

Recurrent Bladder CarcinomaStage II Bladder CancerStage III Bladder Cancer+1 more

Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Metastatic Prostate Carcinoma2 Castration-Resistant Prostate Carcinoma1 Hormone-Resistant Prostate Cancer1 Metastatic Malignant Neoplasm in the Bone1 Prostate Adenocarcinoma1 Prostate Adenocarcinoma Without Neuroendocrine Differentiation1 Recurrent Bladder Carcinoma1 Recurrent Prostate Carcinoma1

Affiliations

Fred Hutch/University of Washington Cancer Consortium

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jeremie Calais

UCLA / Jonsson Comprehensive Cancer Center

9 trials

Shared therapeutic areas:

Metastatic Prostate CarcinomaRecurrent Prostate CarcinomaCastration-Resistant Prostate Carcinoma+5 more

Worked with same sponsors:

Castration-Resistant Prostate CarcinomaProstate AdenocarcinomaMetastatic Prostate Carcinoma+4 more

Similarity Score10%

Michael Schweizer

Fred Hutch/University of Washington Cancer Consortium

11 trials

Shared therapeutic areas:

Worked with same sponsors:

AstraZenecaNational Cancer Institute (NCI)+1 more

Similarity Score9%

Amar Kishan

UCLA / Jonsson Comprehensive Cancer Center

7 trials

Shared therapeutic areas:

Prostate AdenocarcinomaStage II Prostate Cancer AJCC v8Recurrent Prostate Carcinoma+4 more

Similarity Score9%

Rahul Aggarwal, MD

University of California, San Francisco

22 trials

Shared therapeutic areas:

Castration-Resistant Prostate CarcinomaProstate AdenocarcinomaMetastatic Prostate Carcinoma+3 more

Worked with same sponsors:

AstraZenecaNational Cancer Institute (NCI)

Similarity Score8%

Jacek Pinski, MD

University of Southern California

6 trials

Shared therapeutic areas:

Hormone-Resistant Prostate CancerMetastatic Prostate CarcinomaProstate Adenocarcinoma

Worked with same sponsors:

Stage IV Prostate CancerStage III Prostate CancerStage IV Bladder Cancer

Similarity Score4%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

62 trials

Shared therapeutic areas:

Similarity Score4%

A P Chen

National Cancer Institute LAO

8 trials

Shared therapeutic areas:

Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaRecurrent Prostate Carcinoma

Worked with same sponsors:

Prostate AdenocarcinomaRecurrent Prostate Carcinoma

Similarity Score4%

Andrei Iagaru, MD

Stanford University

6 trials

Shared therapeutic areas:

Similarity Score3%

Glenn Lesser, MD

Wake Forest University Health Sciences

10 trials

Shared therapeutic areas:

Prostate AdenocarcinomaStage III Prostate Cancer

Worked with same sponsors:

Stage IIA Prostate CancerStage IIB Prostate Cancer

Similarity Score3%

Stephen Michael Hahn

Abramson Cancer Center at Penn Medicine

6 trials

Shared therapeutic areas:

Worked with same sponsors: